Anzeige
Mehr »
Montag, 20.07.2026 - Börsentäglich über 12.000 News
DER COUNTDOWN LÄUFT: 42 Proben im Labor - Jetzt beginnt die spannendste Phase für diese Wolfram-Aktie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrJasper gets a lifeline in merger with immune drugmaker Kira
FrGSK shelves cough drug acquired in $2B deal
FrArbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances
FrHow well are AI-discovered drugs faring in the clinic?
DoLilly to buy AtaiBeckley for $2.8B, further validating psychedelics
DoVeradermics keeps 'momentum going' as baldness drug helps women with hair loss
DoMerck wins first approval of a PCSK9 cholesterol pill
MiCelcuity gains FDA approval for closely-watched breast cancer drug
MiBraveheart, Attovia join next wave of biotech IPOs
MiMerck ADC, in China study, shows potential to replace chemo in lung cancer
MiJ&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
DiCVS Caremark reaches settlement with FTC over insulin suit
DiJudge orders Apple Tree partner to forfeit oversight of venture fund
DiFresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
DiDraig bags another $65M to speed testing of brain drugs
DiBiogen data highlight promise, questions surrounding tau-targeting Alzheimer's drugs
13.07.Freenome colorectal cancer test data improve on earlier results
13.07.Q32 bounces back to claim study success for alopecia drug
13.07.Agenus surges on study pivot; Apnimed lines up an IPO
13.07.Biotech startup funding gap widens despite rebound in VC investment
10.07.GSK, Hansoh ADC extends survival in lung cancer study
10.07.ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
09.07.Roche scraps two Ionis-partnered Huntington's drugs
09.07.GSK ends brain drug alliance with Alector
09.07.HHS plan to speed drug research won't remove 'self-inflicted' delays